#United States #Tulsa #Low-Dose Naltrexone #Methylene Blue #Craft Telemedicine

Craft Telemedicine Introduces Innovative Telehealth Solutions

Craft Telemedicine has officially launched an innovative telemedicine platform aimed at transforming the accessibility of specialty care. This newly developed service stands out by eliminating traditional subscription models, thereby offering patients unparalleled freedom and choice in their healthcare decisions.

Traditionally, telehealth services often tether patients to monthly subscriptions and restrict them to specific pharmacy networks. In contrast, Craft Telemedicine adopts a pay-per-prescription strategy. This allows patients to pay a single, transparent fee to receive their prescriptions, giving them the liberty to fill these prescriptions at any pharmacy they prefer.

Understanding the Philosophy Behind the Launch

Arlee Riveland, the CEO and Co-Founder of Craft Telemedicine, emphasized the organization's mission by stating, "Clarity is a form of care." He acknowledged that while he didn't initially set out to establish a healthcare enterprise, his goal has always been to create human-centered tools to address real issues in health care. This commitment is demonstrated in their groundbreaking platform.

Filling Critical Gaps in Access to Care

At launch, Craft Telemedicine provides high-quality compounded medications, beginning with Low-Dose Naltrexone and Methylene Blue. These specialized treatments are frequently difficult to access through conventional healthcare channels. Jack Korbutov, Co-Founder and pharmacist at The Art of Medicine, expresses concern regarding the proliferation of online options for Methylene Blue, many of which do not offer pharmaceutical-grade quality or adhere to safety standards.

“Our partnership with The Art of Medicine is crucial,” Riveland noted, as it ensures that patients receive compounded medications that meet rigorous quality standards. The team is composed of industry professionals, including Stephen Stearman, who bring extensive experience from their backgrounds in healthcare entrepreneurship, underscoring their commitment to positive patient outcomes and safety.

Building a Nationwide Network

Craft Telemedicine's strategy includes seeking partnerships with reputable compounding pharmacies across the nation. The platform positions itself as a preferred telemedicine service for these pharmacies, enabling them to grow their patient base without compromising on quality or ethical standards.

Riveland stressed the importance of building a trusted network of compounding pharmacies that share Craft Telemedicine's emphasis on quality and patient care. They aim to restore patient agency and enable them to make informed decisions about their health, rather than simply distributing prescriptions.

As the company expands, Craft Telemedicine is currently available in 25 states with plans to operate in all 50 states by 2026. Patients can access the platform through their website, benefit from transparent pricing, and enjoy the absence of subscription fees.

Conclusion

Craft Telemedicine is paving the way for a significant shift in how specialty care is delivered, prioritizing patient choice and transparency. With its no-subscription model and commitment to quality, the platform is poised to redefine the norms of telemedicine and empower patients in ways traditional healthcare has not succeeded in doing. As they continue to expand, this innovative solution may very well become a lion's share in the evolving landscape of healthcare delivery.